Genenta Science S.p.A. (NASDAQ:GNTA) Sees Large Growth in Short Interest

Genenta Science S.p.A. (NASDAQ:GNTA) saw a large increase in short interest in the month of June. As of June 15th, there was short interest totalling 5,000 shares, an increase of 47.1% from the May 31st total of 3,400 shares. Based on an average trading volume of 4,300 shares, the short-interest ratio is presently 1.2 days.

Wall Street Analyst Weigh In

Separately, HC Wainwright reaffirmed a “buy” rating and set a $25.00 price target on shares of Genenta Science in a research note on Monday, May 13th.

Genenta Science Price Performance

NASDAQ GNTA traded down $0.01 on Monday, reaching $3.10. The company’s stock had a trading volume of 252 shares, compared to its average volume of 4,645. Genenta Science has a twelve month low of $2.20 and a twelve month high of $6.39. The firm’s 50 day moving average is $3.25 and its two-hundred day moving average is $3.82.

Genenta Science Company Profile

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter.